结论泰脂安对阴虚型脂肪肝病人降脂作用比力平之效果好。
TZA has good effect than Lipingzhi on decreasing blood lipid in yin-deficiency type patients with fatty liver.
目的探讨泰脂安胶囊对阴虚型脂肪肝伴高脂血症病人的作用。
Objective To explore the therapeutic effect of Taizhian(TZA) on yin-deficiency type patients with fatty liver(FL) and hyperlipemia.
目的：观察泰脂安对高脂模型大鼠的降脂作用，探讨泰脂安可能的降脂作用机制。
AIM: to observe the effects of Taizhi an capsules on reducing the hyperlipidemia in rat models, and to explore the mechanisms and the side-effects of Taizhi an.
结论：泰脂安对高脂模型大鼠有较好的降脂作用，其降脂作用机制可能与泰脂安升高血清中的脂蛋白脂肪酶含量有关。
CONCLUSION: Taizhi "an capsule can decrease the hyperlipidemia. Its mechanism is related to the regulation of lipid metabolism and improvement of the concentration of LPL (lipoprotein lipase)."
结论：泰脂安对高脂模型大鼠有较好的降脂作用，其降脂作用机制可能与泰脂安升高血清中的脂蛋白脂肪酶含量有关。
CONCLUSION: Taizhi "an capsule can decrease the hyperlipidemia. Its mechanism is related to the regulation of lipid metabolism and improvement of the concentration of LPL (lipoprotein lipase)."
应用推荐